NCAM1 and cancer: We observed that CD56 and/or CD16-positive NK cells (Figure 1C red arrows) could be effortlessly identified in the interface area between cancer cell clusters and the cancer cell lysis site in the MUC1-expressing xenograft tumor tissue.